SCHEMBL5825558

SCHEMBL5825558

CC(Oc1ccccc1Cl)C(=O)Cl

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.59
HPGD P15428 3/20 0.59
MEN1 O00255 2/20 0.59
ALDH1A1 P00352 5/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
MAPT P10636 2/20 0.51
L3MBTL1 Q9Y468 1/20 0.46
TP53 P04637 1/20 0.43
POLB P06746 1/20 0.43
XIAP P98170 1/20 0.42
ADRA2A P08913 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
GHSR Q92847 2/20 0.42
RXFP1 Q9HBX9 1/20 0.42
GAA P10253 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27560928 0.87 HPGD (0.47) KMT2AHPGDMEN1ALDH1A1SMN1; SMN2
SCHEMBL503699 0.85 KMT2A (0.66) KMT2AHPGDMEN1ALDH1A1SMN1; SMN2
SCHEMBL8935734 0.85 KMT2A (0.66) KMT2AHPGDMEN1ALDH1A1SMN1; SMN2
SCHEMBL9367403 0.84 XIAP (0.56) KMT2AHPGDMEN1ALDH1A1SMN1; SMN2
SCHEMBL16244235 0.84 KMT2A (0.57) KMT2AHPGDMEN1ALDH1A1SMN1; SMN2
SCHEMBL28729952 0.82 KMT2A (0.56) KMT2AHPGDMEN1ALDH1A1SMN1; SMN2
SCHEMBL2058985 0.81 HPGD (0.54) KMT2AHPGDMEN1ALDH1A1SMN1; SMN2
SCHEMBL28746514 0.80 ALDH1A1 (0.64) KMT2AHPGDMEN1ALDH1A1SMN1; SMN2
SCHEMBL10778105 0.80 TSHR (0.53) KMT2AHPGDMEN1ALDH1A1SMN1; SMN2
SCHEMBL4585433 0.80 KMT2A (0.54) KMT2AHPGDMEN1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7135466-B2 Quinoline and quinazoline derivatives and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-11-14 US disclosed
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-09-21 US disclosed
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN HOLDINGS KABUSHIKI KAISHA (JP) 2004-07-08 US disclosed
EP-1243582-A1 QUINOLINE AND QUINAZOLINE DERIVATIVES AND DRUGS CONTAINING THE SAME KIRIN BEER KABUSHIKI KAISHA (JP) 2002-09-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA KMT2A 2022/4885HPGD 2351/4885MEN1 3835/4885
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA KMT2A 2006/4885HPGD 2156/4885MEN1 4168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.